Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to ...
The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...
Morning Overview on MSN
Gene editing advances raise real prospects for future DNA upgrades
The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the ...
In May 2025, the world celebrated the success of KJ, an infant who was treated with the world’s first personalized CRISPR gene editing therapy. KJ was born with severe carbamoyl phosphate synthetase 1 ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
By integrating machine learning models into the design process, researchers were able to predict how changes in protein structure would affect editing performance. This allowed them to systematically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results